HuGE Literature Finder
Records
1
-
27
| Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients. British journal of cancer 2021 Oct . Aasebø Kristine, Bruun Jarle, Bergsland Christian H, Nunes Luís, Eide Geir Egil, Pfeiffer Per, Dahl Olav, Glimelius Bengt, Lothe Ragnhild A, Sorbye Halfd |
| Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer. The pharmacogenomics journal 2021 Feb . Suenaga Mitsukuni, Schirripa Marta, Cao Shu, Zhang Wu, Cremolini Chiara, Lonardi Sara, Okazaki Satoshi, Berger Martin D, Miyamoto Yuji, Soni Shivani, Barzi Afsaneh, Yamaguchi Toshiharu, Loupakis Fotios, Falcone Alfredo, Lenz Heinz-Jos |
| Cdx2 Regulates Intestinal EphrinB1 through the Notch Pathway. Genes 2021 2 12 (2): . Zhu Yalun, Hryniuk Alexa, Foley Tanya, Hess Bradley, Lohnes Dav |
| Ethnicity as modifier of risk for Vitamin D receptors polymorphisms: Comprehensive meta-analysis of all cancer sites. Critical reviews in oncology/hematology 2020 Dec 103202. Gnagnarella Patrizia, Raimondi Sara, Aristarco Valentina, Johansson Harriet, Bellerba Federica, Corso Federica, De Angelis Simone Pietro, Belloni Pietro, Caini Saverio, Gandini Sa |
| Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer. Pharmacogenetics and genomics 2020 Jul . Suenaga Mitsukuni, Cao Shu, Zhang Wu, Matsusaka Satoshi, Okazaki Satoshi, Berger Martin D, Miyamoto Yuji, Schirripa Marta, Barzi Afsaneh, Yamamoto Noriko, Yamaguchi Toshiharu, Lenz Heinz-Jos |
| CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup. Frontiers in oncology 2020 3 10 8. Aasebø Kristine, Dragomir Anca, Sundström Magnus, Mezheyeuski Artur, Edqvist Per-Henrik, Eide Geir Egil, Ponten Fredrik, Pfeiffer Per, Glimelius Bengt, Sorbye Halfd |
| Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients. Frontiers in oncology 2020 12 10 563407. Guan Wen-Long, Qiu Miao-Zhen, He Cai-Yun, Yang Li-Qiong, Jin Ying, Wang Zhi-Qiang, Li Yu-Hong, Xu Rui-Hua, Wang Feng-H |
| Reduced Caudal Type Homeobox 2 (CDX2) Promoter Methylation Is Associated with Curcumin's Suppressive Effects on Epithelial-Mesenchymal Transition in Colorectal Cancer Cells. Medical science monitor : international medical journal of experimental and clinical research 2020 9 26 e926443. Chen Ting, Yang Chun, Xi Zhenli, Chen Fen, Li Hail |
| p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy. British journal of cancer 2019 Mar . Oh Hyeon Jeong, Bae Jeong Mo, Wen Xianyu, Jung Seorin, Kim Younghoon, Kim Kyung Ju, Cho Nam-Yun, Kim Jung Ho, Han Sae-Won, Kim Tae-You, Kang Gyeong Ho |
| The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer. Virchows Archiv : an international journal of pathology 2018 Apr . Neumann Jens, Heinemann Volker, Engel Jutta, Kirchner Thomas, Stintzing Sebasti |
| Associations between VDR gene polymorphisms and colorectal cancer susceptibility: an updated meta-analysis based on 39 case-control studies. Oncotarget 2018 Feb 9 (16): 13068-13076. Pan Zhipeng, Chen Mengya, Hu Xingxing, Wang Hua, Yang Jiajia, Zhang Congjun, Pan Faming, Sun Guopi |
| CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clinical epigenetics 2018 9 10 (1): 120. Graule Janina, Uth Kristin, Fischer Elia, Centeno Irene, Galván José A, Eichmann Micha, Rau Tilman T, Langer Rupert, Dawson Heather, Nitsche Ulrich, Traeger Peter, Berger Martin D, Schnüriger Beat, Hädrich Marion, Studer Peter, Inderbitzin Daniel, Lugli Alessandro, Tschan Mario P, Zlobec In |
| Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer. Molecular oncology 2018 6 12 (9): 1639-1655. Bruun Jarle, Sveen Anita, Barros Rita, Eide Peter W, Eilertsen Ina, Kolberg Matthias, Pellinen Teijo, David Leonor, Svindland Aud, Kallioniemi Olli, Guren Marianne G, Nesbakken Arild, Almeida Raquel, Lothe Ragnhild |
| Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survival. Journal of thoracic disease 2017 Oct 9 (Suppl 12): S1282-S1290. Ampollini Luca, Gnetti Letizia, Goldoni Matteo, Viani Lorenzo, Faedda Elisabetta, Campanini Nicoletta, Caruana Pietro, Crafa Pellegrino, Negri Francesca, Pucci Francesca, Leonardi Francesco, Ventura Luigi, Balestra Valeria, Braggio Cesare, Bocchialini Giovanni, Del Rio Paolo, Silini Enrico Maria, Carbognani Paolo, Rusca Miche |
| Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal Cancer. Genetic testing and molecular biomarkers 2016 10 20 (11): 710-714. Jiang Guozhong, Luo Chenglin, Sun Miaomiao, Zhao Zhihua, Li Wencai, Chen Kuisheng, Fan Tian |
| Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2015 Mar . Serrano Davide, Gnagnarella Patrizia, Raimondi Sara, Gandini Sa |
| Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers? Human pathology 2015 11 47 (1): 85-94. Bae Jeong Mo, Rhee Ye-Young, Kim Kyung Ju, Wen Xianyu, Song Young Seok, Cho Nam-Yun, Kim Jung Ho, Kang Gyeong Ho |
| Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality. Cancer epidemiology 2013 Dec 37 (6): 905-7. Perna Laura, Hoffmeister Michael, Schöttker Ben, Arndt Volker, Haug Ulrike, Holleczek Bernd, Burwinkel Barbara, Ordóñez-Mena José M, Brenner Herma |
| Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013 7 27 (1): 145-55. Koestler Devin C, Li Jing, Baron John A, Tsongalis Gregory J, Butterly Lynn F, Goodrich Martha, Lesseur Corina, Karagas Margaret R, Marsit Carmen J, Moore Jason H, Andrew Angeline S, Srivastava Amita |
| The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22. Journal of translational medicine 2013 11 11 297. Pancione Massimo, Remo Andrea, Zanella Caterina, Sabatino Lina, Di Blasi Arturo, Laudanna Carmelo, Astati Laura, Rocco Michele, Bifano Delfina, Piacentini Paolo, Pavan Laura, Purgato Alberto, Greco Filippo, Talamini Alberto, Bonetti Andrea, Ceccarelli Michele, Vendraminelli Roberto, Manfrin Erminia, Colantuoni Vittor |
| Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study. The New Zealand medical journal 2012 Jun 125 (1356): 47-51. Bentley Robert W, Keown Dayle A, Gearry Richard B, Cameron Vicky A, Keenan Jacqui, Roberts Rebecca L, Day Andrew |
| Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 May 20 (5): 1003-16. Touvier Mathilde, Chan Doris S M, Lau Rosa, Aune Dagfinn, Vieira Rui, Greenwood Darren C, Kampman Ellen, Riboli Elio, Hercberg Serge, Norat Tere |
| Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis. International journal of cancer. Journal international du cancer 2010 Jul 127 (2): 367-80. Zlobec Inti, Bihl Michel P, Schwarb Heike, Terracciano Luigi, Lugli Alessand |
| No association between the polymorphisms in CDX2 coding regions and colorectal cancer in Chinese. Molecular and cellular biochemistry 2009 Nov 331 (1-2): 27-30. Xia Xiaoping, Xu Enping, Quan Sheng, Huang Qiong, Lai Mao |
| Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 7 15 (14): 4665-73. Baba Yoshifumi, Nosho Katsuhiko, Shima Kaori, Freed Ellen, Irahara Natsumi, Philips Juliet, Meyerhardt Jeffrey A, Hornick Jason L, Shivdasani Ramesh A, Fuchs Charles S, Ogino Shu |
| CDX2 VDR polymorphism and colorectal cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Dec 16 (12): 2752-5. Slattery Martha L, Herrick Jennifer, Wolff Roger K, Caan Bette J, Potter John D, Sweeney Car |
| CDX2 polymorphisms, RNA expression, and risk of colorectal cancer. Cancer research 2005 Jul 65 (13): 5488-92. Rozek Laura S, Lipkin Steven M, Fearon Eric R, Hanash Samir, Giordano Thomas J, Greenson Joel K, Kuick Rork, Misek David E, Taylor Jeremy M G, Douglas Julie A, Rennert Gad, Gruber Stephen |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: